Hartline Investment Corp’s Merck MRK Stock Holding History

Hartline Investment Corp’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-34,885	Closed	-$4.6M	–	307
2024 Q1	$4.6M	Buy	+34,885	New	+$4.3M	0.81%	24
2022 Q4	–	Sell	-5,387	Closed	-$464K	–	163
2022 Q3	$464K	Buy	+5,387	New	+$481K	0.38%	57

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hartline Investment Corp's MRK Position: Q2 2024 in Review

Hartline Investment Corp sold out of Merck (MRK) in Q2 2024, closing a stake of 34,885 shares — an estimated $4.6M sold.

Hartline Investment Corp first reported a position in MRK in Q3 2022 and held it in 2 quarters. The position peaked at $4.6M in Q1 2024. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

Hartline Investment Corp reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
Hartline Investment Corp sold 34,885 Merck shares in Q2 2024, an estimated $4.6M.
Hartline Investment Corp first reported a position in Merck in Q3 2022 and held it in 2 quarters.
Hartline Investment Corp's Merck position peaked at $4.6M in Q1 2024.
3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Hartline Investment Corp's 13F filing for Q2 2024, filed 9 Aug 2024.